5 Key Takeaways

• 1

  BVI will showcase the Virtuoso dual-function surgical platform at the 2025 EURetina Congress in Paris.

• 2

  Virtuoso is designed for both cataract and vitreoretinal procedures, integrating advanced fluidics control.

• 3

  The platform will feature data on post-occlusion break surge, energy delivery consistency, and aspiration efficiency.

• 4

  Virtuoso has not yet received CE mark approval or FDA 510(k) clearance and is undergoing clinical investigation.

• 5

  The device aims to support both anterior and posterior segment surgeries with enhanced performance capabilities.